English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Researchers report success using fecal transplants to aid immunotherapy response in some cancers
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Lilly and Repertoire partner on T cell therapies in $1.9B autoimmune disease deal
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

AstraZeneca announces $15 billion investment plan for cell therapies and manufacturing in China
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Sanofi sees dip in vaccine sales amid US policy changes but forecasts growth
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Roche targets third place in global obesity drug market after acquisitions
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Biotech investors focus on asset-centric deals amid shifting risks after JPM 2026
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Biotech IPO boom of 2021 faces reality check as sector recalibrates
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Study identifies hundreds of genes linked to type 2 diabetes risk

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes